西藏卫信康医药股份有限公司2025年前三季度权益分派实施公告

Core Viewpoint - The company announced its profit distribution plan for the first three quarters of 2025, detailing a cash dividend of 0.147 yuan per share, which represents 29% of the net profit attributable to shareholders for the same period [2][5][9]. Distribution Plan - The distribution year is set for the first three quarters of 2025 [4]. - The distribution is applicable to all shareholders registered with the China Securities Depository and Clearing Corporation Limited, Shanghai Branch, as of the close of trading on the registration date [4]. - The total number of shares eligible for distribution is 432,334,800 shares after excluding shares held in the company's repurchase account [5]. Dividend Details - The company plans to distribute a total cash dividend of 63,553,215.60 yuan (including tax) [5]. - The cash dividend distribution will not include stock dividends or capital reserve transfers [5]. - The cash dividend per share is calculated as approximately 0.1460 yuan after adjustments [7]. Taxation Information - For individual shareholders, the tax treatment varies based on the holding period of the shares, with a maximum tax rate of 20% for shares held for one month or less [9][10]. - Qualified Foreign Institutional Investors (QFIIs) will have a withholding tax of 10%, resulting in a net cash dividend of 0.1323 yuan per share [11]. - Hong Kong investors will also face a 10% withholding tax, with similar provisions for tax treaty benefits [12]. Implementation Method - Shares held in the company's repurchase account will not participate in the profit distribution [8]. - Cash dividends will be distributed through the clearing system of the China Securities Depository and Clearing Corporation [7].